Search

everythinglearnresearchcommunity

for

Search:↓

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

The niosomes effectively target hair follicles for acne treatment.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Topical 0.1% tacrolimus improved a rare ear condition in cats.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Tideglusib with a bacterial cellulose hydrogel improves wound healing in rats.

Retinoids may improve hair growth in androgenic alopecia when used with other treatments.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Microneedles with enhancer effectively promote hair growth and increase hair density.

Combining imiquimod with diphenylcyclopropenone may improve treatment outcomes for alopecia areata patients who don't respond to diphenylcyclopropenone alone.

The new minoxidil hydrogel is a promising alternative for hair loss treatment, with similar effectiveness and less skin irritation.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Dermatological drugs and cosmetics can cause serious side effects like cancer, allergies, and heart issues.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Researchers created a skin treatment that could effectively deliver medication into hair follicles.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Long-term use of dutasteride for hair loss may harm semen quality.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

The drug combination was safe and showed promise in treating advanced tumors.

The system allows precise control of gene expression in mouse skin, useful for studying skin biology.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Nirogacestat can cause severe skin issues like hidradenitis suppurativa.

Upadacitinib may effectively treat alopecia areata without side effects.

RTA 408 cream protects mice from radiation skin damage.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.